ReviewDiseases (Basel, Switzerland)2024

Safety and Efficacy of GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus with Advanced and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis.

Pajaree Krisanapan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.